Immunologic properties of Epstein-Barr virus-seronegative adults

被引:11
作者
Jabs, WJ [1 ]
Wagner, HJ [1 ]
Neustock, P [1 ]
Kluter, H [1 ]
Kirchner, H [1 ]
机构
[1] UNIV LUBECK,SCH MED,DEPT PEDIAT,D-23538 LUBECK,GERMANY
关键词
D O I
10.1093/infdis/173.5.1248
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epstein-Barr virus (EBV) seronegativity is rare in people > 20 years old. However, some persons remain EBV-seronegative for nearly their whole lives. The aim of this study was to examine properties of the immune system of EBV-seronegative adults that could contribute to long-term EBV seronegativity. Therefore, differential blood cell counts and lymphocyte subpopulations were determined, and the production of interferon (IFN)-alpha and -gamma and interleukin (IL)-6 and -2 in a whole blood assay was investigated. Whereas no differences in the distribution of lymphocyte subpopulations between EBV-seronegative and -positive adults were found, a significant higher percentage of monocytes in EBV-seronegative adults was observed. Significantly more IFN-alpha and IL-6 were detected in culture supernatants of EBV-seronegative persons after stimulation with Newcastle disease virus. In contrast, no differences in the induction of the lymphokines IFN-gamma and IL-2 were seen. These data suggest that faster and higher production of IFN-alpha and IL-6 may protect EBV-seronegative adults against EBV infection.
引用
收藏
页码:1248 / 1251
页数:4
相关论文
共 15 条
[1]   INHIBITION OF EPSTEIN-BARR VIRUS-MEDIATED CAPPING OF CD21 CR-2 BY ALPHA-INTERFERON (IFN-ALPHA) - IMMEDIATE ANTIVIRAL ACTIVITY OF IFN-ALPHA DURING THE EARLY PHASE OF INFECTION [J].
DELCAYRE, AX ;
LOTZ, M ;
LERNHARDT, W .
JOURNAL OF VIROLOGY, 1993, 67 (05) :2918-2921
[2]   EPSTEIN-BARR-VIRUS COMPLEMENT C3D RECEPTOR IS AN INTERFERON-ALPHA RECEPTOR [J].
DELCAYRE, AX ;
SALAS, F ;
MATHUR, S ;
KOVATS, K ;
LOTZ, M ;
LERNHARDT, W .
EMBO JOURNAL, 1991, 10 (04) :919-926
[3]  
DETHE G, 1975, ONCOGENESIS HERPESVI, V11, P3
[4]  
FOSS HD, 1994, BLOOD, V83, P707
[5]  
GERVAIS F, 1981, J IMMUNOL, V126, P897
[6]   INFLUENCE OF VARIOUS FACTORS ON INTERFERON-ALPHA PRODUCTION IN CULTURES OF HUMAN-LEUKOCYTES [J].
KATSCHINSKI, DM ;
NEUSTOCK, P ;
KLUTER, H ;
KIRCHNER, H .
JOURNAL OF INTERFERON RESEARCH, 1994, 14 (03) :105-110
[7]   A WHOLE-BLOOD TECHNIQUE FOR TESTING PRODUCTION OF HUMAN INTERFERON BY LEUKOCYTES [J].
KIRCHNER, H ;
KLEINICKE, C ;
DIGEL, W .
JOURNAL OF IMMUNOLOGICAL METHODS, 1982, 48 (02) :213-219
[8]   THE INTERFERON SYSTEM AS AN INTEGRAL-PART OF THE DEFENSE SYSTEM AGAINST INFECTIONS [J].
KIRCHNER, H .
ANTIVIRAL RESEARCH, 1986, 6 (01) :1-17
[9]  
KURE S, 1986, VIRUS RES, V5, P377
[10]  
LOTZ M, 1986, J IMMUNOL, V136, P3636